GW&K Investment Management’s AstraZeneca AZN Stock Holding History

GW&K Investment Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$53K	Buy	+282	New	+$53K	﹤0.01%	583
2026 Q1	–	Sell	-206	Closed	-$38K	–	1014
2025 Q4	$38K	Hold	206	–	–	﹤0.01%	611
2025 Q3	$32K	Hold	206	–	–	﹤0.01%	624
2025 Q2	$29K	Hold	206	–	–	﹤0.01%	613
2025 Q1	$30K	Hold	206	–	–	﹤0.01%	562
2024 Q4	$27K	Hold	206	–	–	﹤0.01%	558
2024 Q3	$32K	Buy	206 +9	+5%	+$1.45K	﹤0.01%	515
2024 Q2	$31K	Buy	197 +6	+3%	+$903	﹤0.01%	491
2024 Q1	$26K	Buy	191 +35	+22%	+$4.63K	﹤0.01%	496
2023 Q4	$21K	Hold	156	–	–	﹤0.01%	500
2023 Q3	$21K	Hold	156	–	–	﹤0.01%	476
2023 Q2	$22K	Buy	+156	New	+$23K	﹤0.01%	462

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

GW&K Investment Management's AZN Position: Q2 2026 in Review

GW&K Investment Management opened a new position in AstraZeneca (AZN) in Q2 2026: 282 shares worth $53K. The stake represents ﹤0.01% of the portfolio and ranks #583 among its holdings. This is a return to the name: GW&K Investment Management previously reported a position in AZN as recently as Q4 2025.

GW&K Investment Management first reported a position in AZN in Q2 2023 and has held it in 12 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

GW&K Investment Management held 282 shares of AstraZeneca worth $53K as of Q2 2026.
AstraZeneca was a new GW&K Investment Management position in Q2 2026.
AstraZeneca made up ﹤0.01% of GW&K Investment Management's portfolio in Q2 2026, its #583 holding.
GW&K Investment Management first reported a position in AstraZeneca in Q2 2023 and has held it in 12 quarters since.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on GW&K Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.